FiercePharmaAsia—More Takeda deals, China’s pharma supply issues, Merck KGaA expansion

8 years ago

by David Miller

967 Views

Written by David Miller

Takeda made R&D deals in neurological disorders and with academic institutes, China's crackdown on pollution has caused some supply issues for the pharma industry, Merck KGaA plans further manufacturing expansions in Asia, and more.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller